MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2018 International Congress

    Could the rate of dopaminergic medications reduction affect outcome after STN-DBS?

    S. Alusi (Liverpool, United Kingdom)

    Objective: A retrospective analysis of the rate of dopaminergic drugs reduction following subthalamic nucleus Deep Brain Stimulation (STN-DBS) in a group of Parkinson’s disease patients…
  • 2018 International Congress

    Blinded acute assessment of electrode contact efficacy compared with contact location for Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

    G. Lim, B. Jonker, S. Bolitho, S. Tisch (Sydney, Australia)

    Objective: This study aimed to assess the clinical efficacy of each contact and the correlation between the clinical best contacts and radiologically defined optimal contacts.…
  • 2018 International Congress

    STN-DBS responsive motor complication and pathological gambling in type IV SCA3

    M. Kuo, C. Tai, R. Wu (New Taipei, Taiwan)

    Objective: Background: Type IV spinocerebellar ataxia type 3 (SCA3) could present as pure parkinsonism. A bilateral subthalamic nucleus deep brain stimulation (STN-DBS) has been reported…
  • 2018 International Congress

    FXTAS-like Phenotype with p.P626L Missense Mutation: A case report

    X. Duan, L. Zhang, C. Liu, W. Liao, F. Tassone, Y. Yi, R. Hagerman (Shang Sha, China)

    Objective: To describe p.P626L missense mutation of FMR1 gene in a patient with clinical phenotype of Fragile X Associated Tremor and Ataxia Syndrome (FXTAS). Background:…
  • 2018 International Congress

    Pallidal beta bursts in Parkinson’s disease and Dystonia

    R. Lofredi, WJ. Neumann, C. Brücke, J. Huebl, GH. Schneider, A. Kühn (Berlin, Germany)

    Objective: The aim of this study is to test whether prolonged beta burst duration is disease-specific for Parkinson's disease when compared to oscillatory activity in…
  • 2018 International Congress

    Clinical and genetics characterization of patients with Myoclonus Dystonia Syndrome

    B. Perez-Dueñas, M. Vanegas, L. Marti, A. Darling, D. Ortigoza-Escobar, S. Candela, H. Baide, J. Campistol, S. Aguilera, M. Marti, A. Macaya (Barcelona, Spain)

    Objective: To characterize clinically and genetically a series of 23 patients with myoclonus dystonia syndrome (MDS) and to explore the Unified Myoclonus Rating Scale (UMRS)…
  • 2018 International Congress

    DIRECT DBS: A Prospective, Multicenter Clinical Study with Double-Blinding for a Directional Deep Brain Stimulation Lead – Intra-visit Impedance Changes

    F. Steigerwald, J. Volkmann, C. Matthies, A. Dalal Kirsch, S. Chabardes, R. de Bie, PR. Schuurman, E. Moro, V. Fraix, S. Meoni, D. Blum, L. Juarez Paz, K. Wynants, N. Van Dyck (Würzburg, Germany)

    Objective: To evaluate impedance changes throughout the course of a programming visit as a part of a larger directional lead exploration study. Background: Historically, DBS…
  • 2018 International Congress

    Improvement in chorea and function in a patient with dystonia-choreoathetosis cerebral palsy after treatment with bilateral pallidal deep brain stimulation

    Y. Fernandez, B. Kopell, W. Tse (New York, NY, USA)

    Objective: We describe and demonstrate by video a patient with dystonia-choreoathetosis cerebral palsy treated with bilateral pallidal deep brain stimulation (DBS). Background: Dystonia-choreoathetosis cerebral palsy…
  • 2018 International Congress

    Globus pallidus deep brain stimulation (GPi-DBS) in one patient with complex early-onset dystonia and KMT2B mutation: A case report

    O. Morsi, G. Valero, J. Jimenez, J. Lopez, AE. Baidez, B. Cuartero, M. Felipe, R. Sanchez, J. Zamarro (Murcia, Spain)

    Objective: To assess long term results of GPi-DBS in one patient with generalized dystonia with KMT2B mutation. Background: Mutations in heterozygosis of the KMT2B gene,…
  • 2018 International Congress

    Long Term Outcome of the Subthalamic Nucleus DBS for Advanced Parkinson’s Disease: An Eight Years Follow-Up Study in China

    Q. Guo, J. Liu, C. Yang, W. Xian, L. Jiang, S. Xu, W. Chen, Y. Hu, L. Chen (Guangzhou, China)

    Objective: To investigate the long term efficacy and its safety of STN DBS for PD in China with an eight years follow up of ten…
  • « Previous Page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 152
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley